Showing results (2511-2520 of 3,045) with videos related to

Sort By:
Pageof 305
Schweizerische Medizinische Wochenschrift|January 10, 1981
[Cardiovascular risk factors in headquarters staff of the World Health Organization]D Bréguet, A Baczko, J Fabre, et al.
Lancet (London, England)|September 1, 1984
Prevalence of antibody to human T-lymphotropic virus type III in AIDS and AIDS-risk patients in BritainR Cheingsong-Popov, R A Weiss, A Dalgleish, et al.
Parasite Immunology|September 26, 2003
Serum IgG3 to the Plasmodium falciparum merozoite surface protein 2 is strongly associated with a reduced prospective risk of malariaWolfram G Metzger, Daniel M N Okenu, David R Cavanagh, et al.
AIDS (London, England)|August 30, 2008
Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when?Richard G White, Judith R Glynn, Kate K Orroth, et al.
Investigative Ophthalmology & Visual Science|June 23, 2011
What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence settingMatthew J Burton, Victor H Hu, Patrick Massae, et al.
Plastic and Reconstructive Surgery|June 25, 2011
Randomized sham-controlled trial to evaluate the safety and effectiveness of a high-intensity focused ultrasound device for noninvasive body sculptingMark L Jewell, Richard A Baxter, Sue Ellen Cox, et al.
Sexually Transmitted Diseases|April 16, 2019
Self-Collection of Vaginal Swabs Among Adolescent Girls in a School-Setting in East AfricaSuzanna C Francis, George Miiro, Kevin Nakuya, et al.
Frontiers in Endocrinology|March 18, 2022
Peptide Model of the Mutant Proinsulin Syndrome. I. Design and Clinical CorrelationBalamurugan Dhayalan, Michael D Glidden, Alexander N Zaykov, et al.
Protein Science : a Publication of the Protein Society|February 19, 2025
Stabilization of a protein by a single halogen-based aromatic amplifierKrystel El Hage, Balamurugan Dhayalan, Yen-Shan Chen, et al.
Journal of the American Academy of Dermatology|February 8, 2018
Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trialZoe Diana Draelos, Michael H Gold, Robert A Weiss, et al.
Pageof 305